共 50 条
- [41] Drug risks associated with sarcopenia: a real-world and GWAS study BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01):
- [43] Real-world use of nirmatrelvir-ritonavir: who benefits? LANCET INFECTIOUS DISEASES, 2023, 23 (07): : 765 - 767
- [46] Need for and Benefits of Additional Real-World Project Modeling Capabilities 2023 IEEE AEROSPACE CONFERENCE, 2023,
- [49] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization Therapeutic Innovation & Regulatory Science, 2023, 57 : 472 - 475